314 related articles for article (PubMed ID: 23340295)
1. Contribution of OATP1B1 and OATP1B3 to the disposition of sorafenib and sorafenib-glucuronide.
Zimmerman EI; Hu S; Roberts JL; Gibson AA; Orwick SJ; Li L; Sparreboom A; Baker SD
Clin Cancer Res; 2013 Mar; 19(6):1458-66. PubMed ID: 23340295
[TBL] [Abstract][Full Text] [Related]
2. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel.
de Graan AJ; Lancaster CS; Obaidat A; Hagenbuch B; Elens L; Friberg LE; de Bruijn P; Hu S; Gibson AA; Bruun GH; Corydon TJ; Mikkelsen TS; Walker AL; Du G; Loos WJ; van Schaik RH; Baker SD; Mathijssen RH; Sparreboom A
Clin Cancer Res; 2012 Aug; 18(16):4433-40. PubMed ID: 22711709
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.
Hu S; Mathijssen RH; de Bruijn P; Baker SD; Sparreboom A
Br J Cancer; 2014 Feb; 110(4):894-8. PubMed ID: 24398510
[TBL] [Abstract][Full Text] [Related]
4. Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver.
Sato T; Yamaguchi H; Kogawa T; Abe T; Mano N
J Pharm Pharm Sci; 2014; 17(4):475-84. PubMed ID: 25579430
[TBL] [Abstract][Full Text] [Related]
5. Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance.
Lee HH; Leake BF; Teft W; Tirona RG; Kim RB; Ho RH
Mol Cancer Ther; 2015 Apr; 14(4):994-1003. PubMed ID: 25695959
[TBL] [Abstract][Full Text] [Related]
6. Influence of OATP1B1 Function on the Disposition of Sorafenib-β-D-Glucuronide.
Bins S; van Doorn L; Phelps MA; Gibson AA; Hu S; Li L; Vasilyeva A; Du G; Hamberg P; Eskens F; de Bruijn P; Sparreboom A; Mathijssen R; Baker SD
Clin Transl Sci; 2017 Jul; 10(4):271-279. PubMed ID: 28371445
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Mouse Models To Study Human OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions in Vivo.
Durmus S; Lozano-Mena G; van Esch A; Wagenaar E; van Tellingen O; Schinkel AH
Mol Pharm; 2015 Dec; 12(12):4259-69. PubMed ID: 26474710
[TBL] [Abstract][Full Text] [Related]
8. Influence of Tyrosine Kinase Inhibition on Organic Anion Transporting Polypeptide 1B3-Mediated Uptake.
Hove VN; Anderson K; Hayden ER; Pasquariello KZ; Gibson AA; Shen S; Qu J; Jin Y; Miecznikowski JC; Hu S; Sprowl JA
Mol Pharmacol; 2022 Jun; 101(6):381-389. PubMed ID: 35383108
[TBL] [Abstract][Full Text] [Related]
9. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
10. Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice.
van de Steeg E; van Esch A; Wagenaar E; Kenworthy KE; Schinkel AH
Clin Cancer Res; 2013 Feb; 19(4):821-32. PubMed ID: 23243220
[TBL] [Abstract][Full Text] [Related]
11. Organic Anion Transporting Polypeptide-Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens.
Li CY; Gupta A; Gáborik Z; Kis E; Prasad B
Mol Pharmacol; 2020 Sep; 98(3):234-242. PubMed ID: 32587096
[TBL] [Abstract][Full Text] [Related]
12. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
Gui C; Miao Y; Thompson L; Wahlgren B; Mock M; Stieger B; Hagenbuch B
Eur J Pharmacol; 2008 Apr; 584(1):57-65. PubMed ID: 18321482
[TBL] [Abstract][Full Text] [Related]
13. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
[TBL] [Abstract][Full Text] [Related]
14. Interaction of three regiospecific amino acid residues is required for OATP1B1 gain of OATP1B3 substrate specificity.
DeGorter MK; Ho RH; Leake BF; Tirona RG; Kim RB
Mol Pharm; 2012 Apr; 9(4):986-95. PubMed ID: 22352740
[TBL] [Abstract][Full Text] [Related]
15. Isolation of modulators of the liver-specific organic anion-transporting polypeptides (OATPs) 1B1 and 1B3 from Rollinia emarginata Schlecht (Annonaceae).
Roth M; Araya JJ; Timmermann BN; Hagenbuch B
J Pharmacol Exp Ther; 2011 Nov; 339(2):624-32. PubMed ID: 21846839
[TBL] [Abstract][Full Text] [Related]
16. Selectivity and potency of microcystin congeners against OATP1B1 and OATP1B3 expressing cancer cells.
Niedermeyer TH; Daily A; Swiatecka-Hagenbruch M; Moscow JA
PLoS One; 2014; 9(3):e91476. PubMed ID: 24614281
[TBL] [Abstract][Full Text] [Related]
17. Screening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probes.
Yamaguchi H; Takeuchi T; Okada M; Kobayashi M; Unno M; Abe T; Goto J; Hishinuma T; Shimada M; Mano N
Biol Pharm Bull; 2011; 34(3):389-95. PubMed ID: 21372390
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3.
Bednarczyk D
Anal Biochem; 2010 Oct; 405(1):50-8. PubMed ID: 20540932
[TBL] [Abstract][Full Text] [Related]
19. Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics.
Lancaster CS; Sprowl JA; Walker AL; Hu S; Gibson AA; Sparreboom A
Mol Cancer Ther; 2013 Aug; 12(8):1537-44. PubMed ID: 23757163
[TBL] [Abstract][Full Text] [Related]
20. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination.
Smith NF; Figg WD; Sparreboom A
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):429-45. PubMed ID: 16863454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
